Engaging the brain with cognitive tasks helps paralyzed rats walk again.
Covering the life sciences inside and out
Engaging the brain with cognitive tasks helps paralyzed rats walk again.
One cancer researcher says that by focusing solely on stalling cancer growth, clinical trials are failing some potentially life-saving drugs that prevent metastasis.
A protein that keeps the immune response in check leads a double life as an anti-aging factor.
A growth factor isolated from human stem cells shows promising results in a mouse model of multiple sclerosis.
What researchers are learning as they sequence, map, and decode species’ genomes
Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.
From breast milk stem cells to bone repair, this year’s EB conference held a number of exciting advances that could one day be translated into therapies.
Editors at PLoS Medicine suggest that merely disclosing conflicts of interest is insufficient and possibly even counterproductive.
With 12 new tuberculosis vaccines in clinical development, a plan is needed to introduce the most effective ones throughout the world.
A once rare mobile genetic element could be the cause of a MRSA epidemic in Chinese hospitals.